MedTrace Logo

Endoscopic Scoring System Utilization in Inflammatory Bowel Disease

NCT05576402 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2022-12-28

No results posted yet for this study

Summary

Inflammatory bowel diseases comprise two distinctive entities: Crohn's disease and ulcerative colitis. During the last decade, endoscopic assessment of inflammation has become relevant since it is a prognostic factor. As a consequence, therapeutic targets now contemplate mucosal healing as part of the goals to be achieved. Endoscopic scores for Crohn's disease and ulcerative colitis have been developed to objectively assess the mucosal inflammatory activity. Although they may have some limitations, these scores have been widely accepted in referral centers, especially since they have been adopted as standard evaluation in inflammatory bowel disease clinical trials . However, their use in the setting of endoscopic practice outside centers with a high volume or with less experience in clinical trials is not known.

Conditions

  • Inflammatory Bowel Diseases

Interventions

PROCEDURE

colonoscopy

endoscopic exploration of colonic mucosa to evaluate inflammatory activity in patients with either Crohn's disease or ulcerative colitis

Sponsors & Collaborators

  • Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno

    lead OTHER

Principal Investigators

  • Juan S Lasa, MD · Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-02
Primary Completion
2023-01-31
Completion
2023-02-20

Countries

  • Argentina

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05576402 on ClinicalTrials.gov